MediFind

Find a Doctor

Emily K. Bergsland

University Of California San Francisco Medical Center
Oncology, Internal Medicine
Female
Practicing approx. 31 years

Bio


Emily Bergsland is an Oncologist and an Internal Medicine specialist in San Francisco, California. She has been an author on 101 peer reviewed articles and participated in 2 clinical trials in the past 15 years. Dr. Bergsland's top three areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, and Gastroenteropancreatic Neuroendocrine Tumor. She is licensed to treat patients in CA.

Contact

2330 Post St
San Francisco, CA 94143, US

Latest Research


Latest Advance
Study
  • Condition: PD-L1-Positive Advanced Carcinoid or Pancreatic Neuroendocrine Tumors
  • Journal: Cancer
  • Treatment Used: Pembrolizumab
  • Number of Patients: 276
  • Published —
This study tested the safety and efficacy of using pembrolizumab to treat patients with PD-L1-positive advanced carcinoid or pancreatic neuroendocrine tumors.
Latest Advance
Study
  • Condition: Advanced Neuroendocrine Tumors
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Pembrolizumab
  • Number of Patients: 107
  • Published —
This study tested the safety and efficacy of using pembrolizumab to treat patients with advanced neuroendocrine tumors.
Latest Advance
Study
  • Condition: Carcinoid Syndrome
  • Journal: The oncologist
  • Treatment Used: Telotristat Ethyl
  • Number of Patients: 239
  • Published —
The purpose of the study was to assess the safety data from five clinical trials with telotristat ethyl in patients with carcinoid syndrome
Latest Advance
Study
  • Condition: Pancreatic Neuroendocrine Tumors (PNET) Resistant to Everolimus
  • Journal: Molecular cancer therapeutics
  • Treatment Used: Sapanisertib
  • Number of Patients: 0
  • Published —
This study evaluated everolimus and sapanisertib for the treatment of patients with everolimus-resistant pancreatic neuroendocrine tumors (PNET).
Latest Advance
Study
  • Condition: Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1
  • Journal: Pancreas
  • Treatment Used: Surgery
  • Number of Patients: 1
  • Published —
This review discusses a 45-year-old woman with multiple endocrine neoplasia type 1 (MEN1) treated with surgery.

Clinical Trials


Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 42
  • Start Date: August 10, 2017
A Pilot Study of Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas

All Publications
View All


Publication
Study
  • Journal: JCO oncology practice
  • Published —
Reply to S. Boutayeb et al.

Contact

2330 Post St
San Francisco, CA 94143, US

Affiliations

  • Ucsf Medical Center

Credentials

  • Licenses
    Internal Medicine in CA
  • Board Certifications
    Medical Oncology
    Internal Medicine

Insurance

Contact them to find out if they accept your insurance plan.